investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HBV Drug Development

John Tavis

1 Collaborator(s)

Funding source

Industry
This is an early-stage drug discovery project to identify novel inhibitors of HBV as a liver cancer preventative.

Related projects

Frank Gonzalez

Xenobiotic Receptors – Rockville

Liver and intrahepatic bile ducts

Pathology

Paul J Brindley

Role of Liver Fluke Granulin in Cholangiocarcinogenesis

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Role of Cancer Stem Cells in Liver Cancer Heterogeneity and Subtypes

Liver and intrahepatic bile ducts

Pathology

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Liver and intrahepatic bile ducts

Pathology

Ju-Seog Lee

Hippo Pathway in Hepatocellualr Carcinoma

Liver and intrahepatic bile ducts

Pathology

Ningling Kang

Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver

Liver and intrahepatic bile ducts

Pathology

Frank Gonzalez

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers – Rockville

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The role of cancer stem cells in Liver cancer heterogeneity and subtypes

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Identification of Human Hepatocellular Carcinoma Metastasis Genes

Liver and intrahepatic bile ducts

Pathology